Start for free
Start for free
EB

EVA Basel

Europe, Basel-Stadt, Switzerland, Basel

Description

EVA is sparring partner for new entrepreneurs in the Life Sciences with planned base in north-western Switzerland.

Investor Profile

EVA Basel has made 6 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Seed (83%)
  • Series A (17%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical Device
  • Communities
  • Medical
  • Health Care
  • Collaboration
  • Manufacturing
  • Navigation
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EVA Basel frequently co-invest with?

BioValley Business Angels Club (BioBAC)
Co-Investments: 1
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures
Europe, Utrecht, The Netherlands, Bilthoven
Co-Investments: 1
SN
StartAngels Network
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Zürcher Kantonal Bank
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 4
GoBeyond
GoBeyond
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
MA
Microsoft Accelerator
North America, Washington, United States, Redmond
Co-Investments: 1
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
redalpine
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1

What are some of recent deals done by EVA Basel?

POLYNEURON

Basel, Basel-Stadt, Switzerland

Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.

BiotechnologyCommunitiesMedicalMedical Device
SeedMay 14, 2018
Amount Raised: $3,098,373
POLYNEURON

Basel, Basel-Stadt, Switzerland

Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.

BiotechnologyCommunitiesMedicalMedical Device
SeedMay 12, 2016
Amount Raised: $3,088,898
Inthera Bioscience

Schlieren, Zurich, Switzerland

Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.

BiotechnologyHealth CarePharmaceutical
SeedDec 14, 2015
Amount Raised: $3,738,248
Memo Therapeutics

Schlieren, Zurich, Switzerland

Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.

BiotechnologyCollaboration
Series AJul 22, 2015
Amount Raised: $2,300,000
AOT - Advanced Osteotomy Tools

Basel, Basel-Stadt, Switzerland

Advanced Osteotomy Tools engages in the development of medical devices for advanced osteotomy.

ManufacturingMedical DeviceNavigationPharmaceuticalRobotics
SeedJan 25, 2012
Amount Raised: $1,723,818
BioVersys

Basel, Basel-Stadt, Switzerland

BioVersys is a privately held Swiss biopharmaceutical company.

BiotechnologyPharmaceutical
SeedMar 31, 2011
Amount Raised: $2,729,207
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator